Wedbush analyst Heather Behanna reiterated an Outperform rating and boosted her price target on Sarepta Therapeutic (NASDAQ: SRPT) to $66.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change FDA

Sarepta Therapeutics (SRPT) Shares on Watch Amid Chatter of Secondary Stock OfferingSeptember 20, 2016 3:09 PM Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - OppenheimerSeptember 20, 2016 1:18 PM UPDATE: Cowen Upgrades Sarepta Therapeutic (SRPT) to OutperformSeptember 20, 2016 6:41 AM Sarepta Therapeutics (SRPT) Says Exondys-51 List Price to be $300K/YearSeptember 19, 2016 4:13 PM Jefferies Upgrades Sarepta Therapeutic (SRPT) to HoldSeptember 19, 2016 3:29 PM JMP Securities Upgrades Sarepta Therapeutic (SRPT) to Market OutperformSeptember 19, 2016 3:04 PM Sarepta Therapeutics (SRPT) Confirms Accelerated FDA Approval of EteplirsenSeptember 19, 2016 1:40 PM Sarepta Therapeutics Announces FDA Accelerated Approval of EXONDYS 51™ (eteplirsen) injection, an Exon Skipping Therapy to Treat Duchenne Muscular Dystrophy (DMD) Patients Amenable to Skipping Exon September 19, 2016 1:39 PM Sarepta Therapeutic (SRPT) PT Raised to $81 at Needham & CompanySeptember 19, 2016 1:37 PM Sarepta Therapeutics (SRPT) to Hold 4PM ET Investor Call - Bloomberg, Citing PR AgencySeptember 19, 2016 1:37 PM Leerink Partners Upgrades Sarepta Therapeutic (SRPT) to Market PerformSeptember 19, 2016 1:29 PM Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen ApprovalSeptember 19, 2016 1:08 PM Unusual 11 Mid-Day Movers 9/19: (SRPT) (ISLE) (NSAT) Higher; (VICL) (MGT) (MICT) LowerSeptember 19, 2016 12:56 PM Streetinsider.com's Hot Lunchtime Reads 9/19: (PYPL) (WBMD) (SRPT) (FDX)September 19, 2016 12:22 PM Sarepta Therapeutic (SRPT) PT Raised to $102 at BairdSeptember 19, 2016 12:21 PM SunTrust Upgrades Sarepta Therapeutic (SRPT) to NeutralSeptember 19, 2016 11:43 AM Sarepta Therapeutics (SRPT) Shorts Squeezed After Eteplirsen Receives FDA ApprovalSeptember 19, 2016 11:27 AM Sarepta Therapeutics (SRPT) Pushes to Highs Following FDA Approval; +90%September 19, 2016 11:21 AM Piper Jaffray Upgrades Sarepta Therapeutic (SRPT) to OverweightSeptember 19, 2016 10:58 AM Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to BuySeptember 19, 2016 10:41 AM Sarepta Therapeutic (SRPT) Label More Inclusive Than Anticipated - OppenheimerSeptember 19, 2016 10:40 AM William Blair Upgrades Sarepta Therapeutic (SRPT) to OutperformSeptember 19, 2016 10:35 AM Sarepta Therapeutics (SRPT) Pares Gains Following FDA ApprovalSeptember 19, 2016 10:14 AM Sarepta (SRPT) calls active after FDA approves eteplirsen September 19, 2016 10:03 AM Sarepta Therapeutics (SRPT) Shares Resume Trading; Now Up 82% on FDA Eteplirsen ApprovalSeptember 19, 2016 9:59 AM FDA Approves Sarepta Therapeutics' (SRPT) EteplirsenSeptember 19, 2016 9:52 AM Sarepta Therapeutics (SRPT) Granted FDA Accelerated Approval for EteplirsenSeptember 19, 2016 9:51 AM